CTLA4 and melanoma: Similarly, Chen et al. showed significant upregulation of genes associated with IFNγ signaling, antigen presentation, and T cell effector function in on treatment biopsies from 54 melanoma patients treated with sequential anti-CTLA-4 and anti-PD-1 therapies (Chen et al. 2016).